OQROSign up free
Insider trade

Vertex Pharmaceuticals (VRTX): Officer sold ~$22K

David Altshuler, Officer at Vertex Pharmaceuticals, sold ~$22K of Vertex Pharmaceuticals shares.

~$22K
Approx. value · 52 sh @ $424.69
23K
Holds after · shares reported
Traded
May 15, 2025
Filed
May 19, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 11, 2024Congress · 1 personMembers of Congress: 2 purchases
  2. Mar 13, 2025InsiderOfficer sold ~$1.65M of VRTX shares in the open market
  3. Mar 13, 2025CongressDisclosed purchase of VRTX — reported range $15,001 - $50,000
  4. Mar 20, 2025Congress · 1 personMembers of Congress: 2 sales
  5. May 2, 2025InsiderDirector sold ~$202K of VRTX shares in the open market
  6. May 12, 2025CongressDisclosed sale of VRTX — reported range $15,001 - $50,000
  7. May 15, 2025 · this disclosureInsiderOfficer sold ~$22K of VRTX shares in the open market

What came next

  1. May 22, 2025FDAFDA drug approval: Kalydeco
  2. May 22, 2025FDAFDA drug approval: Kalydeco
  3. Jun 10, 2025CongressDisclosed partial sale of VRTX — reported range $1,001 - $15,000
  4. Jun 11, 2025Congress · 1 personMembers of Congress: 2 sales
  5. Aug 6, 2025Insider · 2 peopleInsiders: 4 purchases (~$5.8M)
  6. Aug 7, 2025CongressDisclosed purchase of VRTX — reported range $1,001 - $15,000
  7. Aug 27, 2025InsiderDirector sold ~$103K of VRTX shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Vertex Pharmaceuticals

For Vertex Pharmaceuticals, OQRO holds 3 insider filings (SEC Form 4 or Form 144) and 1 Congress trade report dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VRTX page.

Other recent filings by David Altshuler, EVP, Chief Scientific Officer

The full history of David Altshuler, EVP, Chief Scientific Officer is on the profile page.

How this filing works

Explore the data

Other disclosures at Vertex Pharmaceuticals

Everything OQRO holds on this company is on its VRTX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data